Department of Internal Medicine II - Haematology, Oncology


  • Prof. Dr. med. Dr. rer. nat. Michael Kneba

The Department of Medicine II, specialising in haematology and oncology, and with two locations on the UKSH's Campus Kiel and in the Städtisches Krankenhaus Kiel (community hospital Kiel), is the largest haematology oncology maximum care hospital in Schleswig-Holstein. It offers all treatment procedures including autologous and allogeneic blood stem cell transplants. An interdisciplinary oncological outpatient department is located on the UKSH's Campus Kiel, which is operated jointly with the Department of General and Thoracic Surgery. There is also an inpatient department. The Department is also home to the Dr. Mildred-Scheel-Haus, the centre for bone marrow and stem cell transplantation and cellular immunotherapy. The Division of Stem Cell Transplantation and Immunotherapy is also part of the Department of Medicine II.

The medical focus is on the diagnostics and treatment of malignant organ tumours and conditions of the haematopoietic system, blood clotting disorders and infectious diseases (speciality in HIV medicine). Patients with haematological and oncological diseases are treated promptly and comprehensively in interdisciplinary tumour outpatient clinics at both locations. The special outpatient department operates as a central starting point for all of Schleswig-Holstein.

The Department is part of the Krebszentrums Nord/Comprehensive Cancer Center. It also works closely with the UKSH tumour centre, which supports both hospital and outpatient care. This means that medical and psychosocial support can be integrated at an early stage in the patient's care.

Division of Stem Cell Transplantation and Immunotherapy

Head of the Division:

  • Prof. Dr. med. Martin Gramatzki

The Division of Stem Cell Transplantation and Immunotherapy is located in the Dr. Mildred-Scheel-Haus. The building is equipped with modern clean rooms and internal and paediatric haematologists work here in close interdisciplinary co-operation, to provide over 100 patients annually with haematopoietic stem cell transplants.

The division is a member of the European Group for Blood and Marrow Transplantation (EBMT) and is accredited according to the international criteria of the JACIE (Joint accreditation committee ISCT and EBMT). In addition to stem cell transplantation, a competence centre for targeted treatment procedures (monoclonal anti-bodies, immune cells and "small molecules") has also been set up here.  Wards, outpatient departments, cell apheresis units and a Good Manufacturing Practice (GMP) laboratory for the production of innovative marketable drugs and translational research are inextricably linked.

The scientific work is based on international co-operation and support from significant research sponsors such as the DFG (German Research Foundation), Deutsche Krebshilfe (German Cancer Aid), and the José Carreras-Stiftung and W. Sander-Stiftung. Research and clinical work has a special focus on the pathophysiology and treatment of plasma cell tumours. The division is fully integrated into the university teaching.